About Beth Bioinformatics
Beth Bioinformatics is a Healthcare company based in Hong Kong (China) founded in 2018. It operates as a vaccines are developed using AI and bioinformatics for genomic analytics. Its focus areas include Life Sciences, Genomics, Genome Informatics and Integrative Bioinformatics Platforms. Similar companies include Helix, Benchling, BioAge Labs, Ingenuity Systems and Genuity Science and 3 more; 7 of its 8 listed similar companies have raised funding.
Company details
Beth Bioinformatics was founded in 2018 and is based in Hong Kong, China. Operations focus on the bioinformatics sector, where precision medicine is advanced through smart technology in genomic sequencing. Automatic software has been created to simulate influenza vaccine strains for upcoming seasons via artificial intelligence and bioinformatics. Prediction tools for human complex disorders are also developed, utilizing omics genetic data and clinical datasets.
- Headquarters Hong Kong, China
- SectorsHealthcare
- Email••••••••
- Website bethbio.com
Similar companies to Beth Bioinformatics
Beth Bioinformatics has 8 listed similar companies in our database, 7 of them funded. They include Helix, Benchling, BioAge Labs, Ingenuity Systems and Genuity Science, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| helix.com | 2015 | San Francisco, United States | $435M | – | Genomic database for clinical research is provided. | |
| benchling.com | 2012 | San Francisco, United States | $411.9M | 640 | Cloud-based bioinformatics platform is offered for biotech research. | |
| bioagelabs.com | 2015 | Vallejo, United States | $293.9M | 43 | Bioinformatics platform is provided for biomarkers and drug discovery. | |
| ingenuity.com | 1998 | Redwood, United States | $20.4M | 30 | Genomic data is analyzed and interpreted via web-based applications. | |
| genuitysci.com | 2013 | Boston, United States | $515M | – | AI-based omics data analysis solutions are provided to researchers. | |
| ntxbio.com | 2016 | Santa Fe, United States | $74.76M | – | Provider of bio informatics platform to develops biologics and therapeutics | |
| inpharmatica.co.uk | 1998 | London, United Kingdom | – | 62 | Developer of predictive informatics based platform for drug discovery | |
| deepcure.com | 2018 | Boston, United States | $64.6M | – | Developer of novel small molecule therapies for immune diseases |
Detailed similar companies of Beth Bioinformatics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
10 companies that operate in the same segment as Beth Bioinformatics (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 562 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Beth Bioinformatics
Beth Bioinformatics was founded in 2018.
Beth Bioinformatics is headquartered in Hong Kong, China.
Beth Bioinformatics was founded in 2018 and is based in Hong Kong, China. Operations focus on the bioinformatics sector, where precision medicine is advanced through smart technology in genomic sequencing. Automatic software has been created to simulate influenza vaccine strains for upcoming seasons via artificial intelligence and bioinformatics. Prediction tools for human complex disorders are also developed, utilizing omics genetic data and clinical datasets.
Beth Bioinformatics's top competitors include Helix, Benchling and BioAge Labs.